S-1/A: Capstone Holding Corp. Files Amended S-1 for $20 Million Equity Line, Highlighting Strategic Growth and Dilution

Sentiment:

Amendment to Registration Statement for Public Offering 9 June 2025 5:00 PM

Capstone Holding Corp., a building products distributor, has filed an amended S-1 registration statement for the potential resale of over 5.19 million shares by a selling stockholder, signaling a strategic equity line financing of up to $20 million to fuel its growth initiatives despite significant shareholder dilution.

Capital raiseThe company has entered into a Common Stock Purchase Agreement with Tumim Stone Capital, LLC, allowing it to sell up to $20.0 million in common stock over approximately 24 months.As consideration for the commitment, Capstone is obligated to issue 215,054 Commitment Shares to Tumim Stone Capital.The proceeds from these sales will be used for working capital and general corporate purposes.

Worse than expectedThe company reports a net tangible book value deficit of $(1.34) per share as of March 31, 2025.The offering is expected to result in an immediate dilution of $(2.50) per share to new investors, and the as-adjusted net tangible book value deficit per share will remain negative at $(0.68).

Summary

Capstone Holding Corp. (CAPS) has filed an Amendment No. 1 to its S-1 Registration Statement, primarily related to the potential resale of up to 5,190,251 shares of common stock by Tumim Stone Capital, LLC, the selling stockholder.
The shares consist of 215,054 Commitment Shares and 4,975,197 Equity Line Securities, issued under a Common Stock Purchase Agreement dated May 14, 2025.
The Company itself is not selling shares in this prospectus and will not receive proceeds from the selling stockholder's resales; however, it may receive up to $20.0 million in gross proceeds from its own sales of common stock to Tumim Stone Capital under the Purchase Agreement for working capital and general corporate purposes.
Capstone Holding Corp. operates as a building products distribution network, with its primary subsidiary Instone being a leading distributor of thin veneer stone and related masonry products in the U.S., serving residential and commercial markets.
The company is a 'controlled company' under Nasdaq rules, with entities controlled by CEO Matthew Lipman and Chairman Michael Toporek owning over 50% of common and voting stock, though it does not intend to rely on associated corporate governance exemptions.
As of March 31, 2025, the company reported a historical net tangible book value (deficit) of $(6,952,292), or $(1.34) per share.
After giving effect to the issuance of 5,190,251 shares at an assumed price of $1.82 per share, the as-adjusted net tangible book value (deficit) would be approximately $(7,083,792), or $(0.68) per share, representing an immediate dilution of $(2.50) per share to new investors.
The company's long-term growth strategy focuses on leveraging its deep team expertise, strategic timing for M&A in the building products sector, and expanding market presence, product portfolio, and operational excellence.
Recent corporate actions include a follow-on public offering of 1,250,000 shares closed on March 7, 2025, and the uplisting of its common stock to the Nasdaq Capital Market under 'CAPS' on March 6, 2025.
The company completed a restructuring on March 7, 2025, gaining 100% ownership of its primary operating subsidiary, TotalStone, LLC, which operates under the trade names Instone and Northeast Masonry Distributors (NMD).

Sentiment

Score: 6

Explanation: The sentiment is cautiously positive. While the company faces significant dilution and a net tangible book value deficit, the secured equity line provides crucial capital for its stated growth strategy, which aligns with positive industry M&A trends. The experienced management team and recent Nasdaq listing are also favorable.

Positives

The company has secured an equity line financing agreement with Tumim Stone Capital, LLC for up to $20.0 million, providing access to capital for working capital and general corporate purposes.
Capstone's operating subsidiary, Instone, has shown revenue growth from approximately $32.2 million in April 2020 to approximately $44.9 million by December 31, 2024.
The company has a 'deep team' controlled by Brookstone Partners, a private equity group with 25 years of expertise in building products investment, including seasoned operating executives and M&A professionals.
Capstone believes it is 'strategically positioned to capitalize on market conditions within the building products sector,' noting that 'acquiring companies at interest rate peaks has yielded strong returns'.
The company has a proven track record of successfully integrating four acquisitions since 2006, laying a solid foundation for continued expansion.
Instone's geographic distribution footprint covers 31 states, providing a strong base for both 'scale and scope acquisitions'.
The introduction of the 'Toro family of manufactured stone products' is expected to 'help drive significant organic revenue growth in the next three years', demonstrating a commitment to innovation.
The company's common stock began trading on the Nasdaq Capital Market under the symbol CAPS on March 6, 2025, enhancing its public market visibility and liquidity.

Negatives

The offering involves significant dilution for existing stockholders, with an immediate dilution of $(2.50) per share to new investors based on the assumed sale price.
The company has a historical net tangible book value (deficit) of $(6,952,292) or $(1.34) per share as of March 31, 2025, which is projected to increase to $(7,083,792) or $(0.68) per share after the offering.
The company's ability to access the full $20.0 million from the equity line depends on market conditions and other factors, and there is no guarantee it will receive the full amount.
Even if the full $20.0 million is raised, the company 'may still need additional capital to fully implement its business, operating and development plans'.
The purchase price per share for the equity line securities will fluctuate based on market prices, making the total number of shares to be issued and the aggregate proceeds uncertain.
The company is a 'controlled company' due to significant ownership by related entities, which could impact corporate governance, although they state they do not intend to rely on exemptions.

Risks

It is not possible to predict the actual number of shares the company will sell under the Purchase Agreement or the actual gross proceeds, as sales depend on market conditions and company discretion.
The company may not have access to the full $20.0 million available under the Purchase Agreement, which could materially adversely affect its liquidity if other funding sources are unavailable or prohibitively dilutive.
Any issuance and sale of a substantial amount of common stock under the Purchase Agreement could cause additional substantial dilution to stockholders.
Investors who buy shares at different times will likely pay different prices and may experience different levels of dilution and investment outcomes.
Future sales by the selling stockholder at prices below the current market price could adversely affect the market price of the common stock.
The company may require additional financing beyond the $20.0 million to fully implement its business plan, and unavailability or prohibitive expense of such financing could materially adversely affect its business, operating results, financial condition, and prospects.
Management will have broad discretion over the use of proceeds from the equity line, and such uses may not improve financial condition or market value.
Future equity offerings or other issuances of common stock or other securities might result in significant dilution and could cause the price of common stock to decline.

Future Outlook

Capstone Holding Corp. aims for long-term growth by leveraging its experienced team and strategic timing for M&A in the building products sector, particularly during periods of interest rate peaks. The company plans to expand its market presence, enhance its product portfolio (e.g., 'Toro' manufactured stone products expected to drive significant organic revenue growth in the next three years), optimize operations, and maintain a customer-centric approach. Proceeds from the equity line financing will be used for working capital and general corporate purposes to support these initiatives.

Management Comments

"We believe we are strategically positioned to capitalize on market conditions within the building products sector."
"Historically, acquiring companies at interest rate peaks has yielded strong returns."
"We expect Toro to help drive significant organic revenue growth in the next three years."

Industry Context

The filing highlights a strategic focus on the building products distribution and manufacturing industry, citing the 2024 Bain & Company Global M&A Report. This report suggests that building products companies making frequent and material acquisitions significantly outperform inactive companies in total shareholder returns (9.6% vs. 2.7%). The current M&A environment is seen as opportune due to 'ample one-off opportunities to acquire struggling assets' and reduced competition from financial investors, particularly in North America. Capstone's strategy aligns with these trends, emphasizing both 'scale' and 'scope' M&A to build product, geography, and capability adjacencies.

Comparison to Industry Standards

The company's M&A strategy is supported by the Bain & Company Global M&A Report 2024, which indicates that building products companies making frequent and material acquisitions achieve significantly higher total shareholder returns (9.6%) compared to inactive companies (2.7%).
The leadership team includes Charles 'Chuck' Dana, who spent 19 years at Owens Corning, a 'leading building materials company', providing industry expertise and a benchmark for operational excellence and strategic growth.
The company's past investment in Woodcrafters Home Products Holdings LLC, which yielded a sale for $32 million from an $8.8 million investment, demonstrates a successful track record in line with industry M&A value creation.

Corporate Governance

Change Type	Description	Effective Date	Impact Assessment
Authorized Share Capital Increase	On February 20, 2025, the authorized shares of Common Stock were increased from 205,000 to 50,000,000, and preferred stock from 5,000 to 25,000,000.	February 20, 2025	Enables the company to issue a larger number of shares for future capital raises, including the current equity line, but also facilitates potential dilution.
Series B Preferred Stock Designation	On February 20, 2025, 2 million shares of authorized preferred stock were designated as Series B Preferred Stock.	February 20, 2025	Creates a new class of preferred stock, potentially for strategic financing or control purposes, as seen with the sale of 985,063 shares to Nectarine Management LLC (a related party).
Tax Benefit Preservation Plan Cancellation	The Tax Benefit Preservation Plan, adopted May 1, 2024, to protect net operating losses and other tax attributes, was cancelled.	March 3, 2025	Removes a mechanism designed to protect valuable tax assets, potentially increasing vulnerability to ownership changes that could limit their use.
Bylaws Amendment (Planned)	The company shall cause its board of directors to amend the bylaws to permit stockholder action by written consent.	As soon as practicable, but no later than five Trading Days following the Closing Date (May 14, 2025)	Increases shareholder influence by allowing actions without a formal meeting, potentially streamlining corporate decision-making or facilitating shareholder-led initiatives.

Legal Proceedings

The company states that, to its knowledge, there are no legal or governmental proceedings pending or threatened that would have a Material Adverse Effect or are required to be described in SEC Documents and are not.

Related Party Transactions

Capstone is a 'controlled company' as entities controlled by Matthew Lipman (CEO) and Michael Toporek (Chairman) own over 50% of its common and voting stock.
In July 2017, the company entered into a Securities Purchase, Loan and Security Agreement with BP Peptides, LLC (a Brookstone entity), involving $3,440,000 in funding.
In December 2020, Brookstone exercised an option to convert $572,700 of accrued interest and secured debt into 24,900 shares of Common Stock.
In March 2022, Brookstone exercised an option to convert $688,104 of accrued interest and $1,951,260 of secured debt into 78,153 shares of Common Stock, increasing its ownership to 77.3% of outstanding Common Stock.
In November 2023, Capstone and Brookstone Acquisition Partners XXI, LLC (a related entity) agreed to terms of an unsecured promissory note for $800,000 related to an investment in Diamond Products Holdings, LLC (DPH), which was controlled by Brookstone XXI.
The $8 million secured note payable to Brookstone XXI related to the DPH investment was forgiven, resulting in a $7.2 million gain on extinguishment of debt for Capstone.
On November 11, 2024, BP Peptides, LLC and the Company amended and extended a promissory note with a principal of $700,617.52 and accrued interest of $101,810.28 to June 30, 2026.
On February 25, 2025, Nectarine Management LLC, an entity controlled by Michael Toporek, purchased 985,063 shares of Series B Preferred Stock for $30,000.
The restructuring of TotalStone, LLC on March 7, 2025, involved the exchange of Class B and Class C membership interests for 3,782,641 shares of the Company's Common Stock, and TotalStone's special preferred interests were exchanged for debt obligations under the Company's credit agreement with Stream Finance, LLC.

Stakeholder Impact

**Shareholders**: Existing shareholders will experience significant dilution due to the issuance of new shares under the equity line. The net tangible book value per share will decrease. The 'controlled company' status means certain corporate governance exemptions could be utilized, though the company states it does not intend to.
**New Investors (via selling stockholder)**: Will face immediate dilution compared to the company's net tangible book value. The purchase price will fluctuate based on market prices, leading to varying investment outcomes.
**Employees**: The strategic growth plan, including M&A and operational excellence, could lead to expanded opportunities or integration challenges.
**Customers**: The focus on expanding market presence, enhancing product portfolio (e.g., Toro products), and operational excellence aims to provide high-quality products and exceptional service, potentially benefiting customers.
**Creditors**: The capital raise provides additional liquidity, which could improve the company's ability to service its existing debt obligations, including those with related parties like Stream Finance, LLC and Berkshire Bank.

Next Steps

Obtain stockholder approval to issue shares of Common Stock in excess of the 19.99% Exchange Cap under Nasdaq listing rules, unless the average purchase price exceeds $1.77.
File additional registration statements with the SEC if more shares need to be registered for resale under the equity line agreement.
Amend the company's bylaws to permit stockholder action by written consent as soon as practicable, but no later than five Trading Days following the Closing Date.
Continue to expand market presence, enhance product portfolio, optimize operations, and focus on customer satisfaction as part of the long-term growth strategy.

Key Dates

Date	Description
1987	Company formed as OrthoLogic Corp.
2005	Company filed its restated certificate of incorporation.
2010	Company changed its name to Capstone Therapeutics Corp.
August 22, 2019	Company effected a 1-for-1,000 reverse stock split of Common Stock.
April 1, 2020	Company obtained a 100% interest in TotalStone, LLC (dba Instone).
December 2020	Brookstone converted $572,700 of accrued interest and secured debt into 24,900 shares of Capstone Common Stock.
February 18, 2022	Company legally changed its name from Capstone Therapeutics Corp. to Capstone Holding Corp.
March 2022	Brookstone converted $688,104 of accrued interest and $1,951,260 of secured debt into 78,153 shares of Capstone Common Stock.
November 2023	Capstone and Brookstone Acquisition Partners XXI, LLC agreed to terms of an unsecured promissory note for $800,000.
March 31, 2024	The $800,000 unsecured promissory note was formalized and issued.
May 1, 2024	Board authorized and declared a dividend distribution of one right for each outstanding share of Common Stock (Tax Benefit Preservation Plan).
November 11, 2024	BP Peptides, LLC and the Company agreed to terms of the Second Amended and Restated Note with a principal amount of $700,617.52 and accrued interest of $101,810.28.
December 31, 2024	Instone's revenues reached approximately $44.9 million.
February 20, 2025	Company filed an amendment to its Restated Certificate of Incorporation to increase authorized shares of Common Stock to 50,000,000 and preferred stock to 25,000,000. Also filed a Certificate of Designation for 2 million shares of Series B Preferred Stock.
March 3, 2025	Tax Benefit Preservation Plan was cancelled per Master Exchange and Other Transaction Agreement.
March 6, 2025	Company's Common Stock began trading on the Nasdaq Capital Market under the symbol CAPS. Nectarine Management LLC purchased 985,063 shares of Series B Preferred Stock.
March 7, 2025	Company closed its follow-on public offering of 1,250,000 shares of Common Stock. Restructuring completed, making the Company the sole member of TotalStone.
March 31, 2025	End of the fiscal period for which net tangible book value was reported.
April 1, 2025	Management agreement between TotalStone and the Company was terminated.
May 14, 2025	Company entered into the Common Stock Purchase Agreement and a Registration Rights Agreement with Tumim Stone Capital, LLC.
May 15, 2025	Placement agency agreement with Joseph Gunnar & Co., LLC was dated.
May 30, 2025	Closing sale price of Common Stock was $1.82 per share.
June 9, 2025	Amendment No. 1 to Form S-1 filed with the SEC.
June 30, 2026	Maturity date for the $800,000 unsecured promissory note and the $700,617.52 principal note to BP Peptides, LLC.

Recommendation

hold

Keywords

Capstone Holding Corp, CAPS, SEC filing, S-1/A, equity line, public offering, common stock, dilution, building products, Instone, masonry products, distribution network, corporate governance, risk factors, Nasdaq Capital Market, Tumim Stone Capital, Brookstone Partners, M&A strategy, financial reporting

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.